INTRODUCTION {#s1}
============

In patients with cardiac disease, it is becoming increasingly clear that peripheral (skeletal muscle) factors, in addition to central (cardiac) factors, play an important role in the determination of exercise tolerance, clinical status, and quality of life[@r1]^)^. Recently, cardiac rehabilitation programs have focused on skeletal muscles[@r2], [@r3]^)^. It is clinically important to evaluate oxidative metabolism in skeletal muscles and establish a conventional index that can be widely used in routine clinical practice. This approach should interest clinicians who need noninvasive tools, allowing quantitative and longitudinal evaluation of metabolic impairment, which can be used for patient follow-up and assessment of therapies or other interventions.

At exercise onset, the fundamental adjustment of pulmonary oxygen uptake (VO~2~) kinetics during moderate-intensity exercise \[i.e., exercise performed below the intensity corresponding to the anaerobic threshold (AT)\] may be considered to represent a functional evaluation tool of oxidative metabolism at the skeletal muscle level. The rate of this adjustment, given by the VO~2~ time constant (τVO~2~), provides a useful insight into the integrated functioning of the cardiovascular, pulmonary, and muscular systems. Aerobic fitness may be defined as the ability to deliver O~2~ to skeletal muscles and utilize it to generate energy during exercise. In healthy individuals, it is largely accepted that τVO~2~ is determined by sluggish activation of enzymes and provision of substrates for mitochondrial oxidative phosphorylation (i.e., oxidative inertia hypothesis and O~2~ utilization limitation hypothesis)[@r4],[@r5],[@r6]^)^, but it may be constrained by the rate of O~2~ delivery to active muscle fibers (i.e., O~2~ delivery limitation hypothesis)[@r7], [@r8]^)^. Doria et al[@r9]^)^. recently reported that an improvement in τVO~2~ is highly correlated with percent increase in mitochondrial protein following exercise training, but this occurs without improvement in the dynamics of O~2~ delivery. This investigation indicates that τVO~2~ may be an evaluation index capable of reflecting the ability of skeletal muscle to utilize O~2~.

However, further investigation relevant to the relationship between τVO~2~ and skeletal muscle fatigue resistance is required. Skeletal muscle fatigue resistance was evaluated by the rate of decline in electromyographic (EMG) mean power frequency (MPF) (EMG MPF~rate~) as an index for evaluating muscle fatigue during sustained isometric muscle actions[@r10], [@r11]^)^. Several studies have suggested that when fatiguing isometric contractions are performed at low levels \[\<30% maximal voluntary contraction (MVC)\], fatigue assessed by EMG changes is primarily due to neural changes, whereas at higher levels (\>45% MVC), fatigue is primarily caused by metabolic factors[@r12], [@r13]^)^. EMG MPF~rate~, measured at higher contraction levels, is an evaluation index reflecting the ability of skeletal muscle to utilize O~2~.

In this report, we discussed the relationships of τVO~2~ with skeletal muscle fatigue resistance (EMG MPF~rate~) and peak oxygen uptake (VO~2peak~) in healthy young adults, which reflect the ability to deliver O~2~ to skeletal muscle[@r14]^)^ and determined the validation of τVO~2~ in assessing the ability of skeletal muscle to utilize O~2~. We hypothesized that τVO~2~ may be more highly correlated with EMG MPF~rate~ than VO~2peak~.

SUBJECTS AND METHODS {#s2}
====================

Subjects
--------

In this study, 12 healthy male subjects volunteered and gave written consent to participate. The ages, heights, masses, and body fat percentages of the subjects (mean ± SD) were 20 ± 1.7 years, 1.70 ± 0.05 m, 62.2 ± 7.0 kg, and 21.6 ± 2.1%, respectively. All procedures were approved by the Ethics Committee of Seirei Christopher University (approval No. 09007). All participants were recreationally active and nonsmokers. No participant was taking medications that would affect the cardiorespiratory response to exercise.

Methods
-------

Participants visited the laboratory for physiological testing on four occasions within a 10-day period. To allow adequate recovery and minimize circadian/diurnal variations, each test was separated by at least 48 h and was performed at approximately the same time of the day. On day one, a maximal treadmill ramp test (0% grade; 1 km/h/min) was performed (AR-200, Minato Medical Science Co., Ltd., Osaka, Japan) to determine VO~2peak~ and AT. VO~2peak~ was arbitrarily defined as the highest VO~2~ value attained during two consecutive 20-s periods. AT was defined as the VO~2~ at which CO~2~ production (VCO~2~) began to increase out of proportion in relation to VO~2~ with a systematic rise in the minute ventilation-to-VO~2~ ratio and end-tidal partial pressure of O~2~, whereas the minute ventilation-to-VO~2~ ratio and end-tidal partial pressure of CO~2~ were stable. From the results of this ramp test, a moderate-intensity running speed was selected to elicit a VO~2~ equivalent to approximately 80−90% of the VO~2~ at AT. In each of the subsequent two visits to the laboratory, subjects performed two-step transitions at a moderate-intensity running speed. Exercise was performed continuously, the duration of each step transition was 6 min, and each transition was preceded by a baseline of 4 km/h/min walking that lasted for 6 min. Changes in the treadmill speed were initiated as a step function without warning the subjects. During the last day of testing, MVC was determined, and one continuous, fatiguing, isometric muscle action was performed until voluntary exhaustion at approximately 60% MVC. All isometric ankle flexion testing was performed on the dominant leg (based on kicking preference). The isokinetic dynamometer (Biodex System 3, Sakai Medical Co., Ltd., Tokyo, Japan) was adjusted at an ankle joint angle of 15° of plantar flexion in the sitting position with the hip and knee at 90°. Subjects performed three 5 s MVCs, that were interspersed with 5 s of rest. The highest torque developed during the three attempts was used as the individual's MVC. After 10 min rest, 60% MVC was set as the marker on the dynamometer screen, and each subject performed one continuous, fatiguing, isometric muscle action of the plantar flexors at approximately 60% MVC until exhaustion (through visual feedback). We defined the exhaustion level as a drop in torque greater than 50% MVC.

During all treadmill exercise sessions, pulmonary gas exchange was measured breath-by-breath using a metabolic measurement system (A-E 300S, Minato Medical Science Co., Ltd., Osaka, Japan). Inspired and expired gas volumes were measured using a hot-wire respiratory flow system. The expired fractions of O~2~ and CO~2~ were analyzed using a paramagnetic O~2~ analyzer and an infrared CO~2~ analyzer, respectively. The system was calibrated prior to each exercise test according to the manufacturer's instructions. The volume was calibrated before each exercise test by manually pumping a 2-L syringe. The O~2~ and CO~2~ analyzers were calibrated by gases of known concentration before each exercise test. Breath-by-breath VE, VO~2~, and VCO~2~ were determined, and the results were stored on a hard disk for subsequent analyses. VO~2~ values were filtered by removing aberrant values that were more than 4 SD of the local mean. Further, each transition value was linearly interpolated to 1-s intervals and time aligned so that time zero represented the onset of exercise. Each transition value was ensemble averaged to yield a single, average response for each subject. This transition was further time averaged into 5-s bins to provide a single time-averaged response for each subject. The on-transient response for VO~2~ was fitted using a mono-exponential model of the formwhere Y (t) represents VO~2~ at any time (t); Y Bsln is the baseline VO~2~ during 4 km/h/min walking; Amp is the steady-state increase in VO~2~ above the baseline value; τ is the time constant defined as the duration of time for VO~2~ to increase to 63% of the steady-state increase; and TD is the time delay (so that the model is not constrained to pass through the origin.) After excluding the initial 20 s of values, while still allowing TD to vary freely (to optimize the accuracy of parameter estimates), VO~2~ values were modeled from 20 s to 4 min (240 s) of the step transition; this ensured that each subject had attained a VO~2~ steady-state, yet did not bias the model fit during the on-transient[@r15], [@r16]^)^. Model parameters were estimated by least-squares nonlinear regression (Microsoft Office Excel 2010, Microsoft Japan Co., Ltd., Tokyo, Japan) in which the best fit was defined by minimization of the residual sum of squares and minimal residual variations around the Y-axis (Y=0).

EMG (Noraxon) of the soleus was continuously recorded at a sampling frequency of 1,500 Hz using bipolar 34-mm diameter Ag-AgCl electrodes (Blue Sensor, Ambu A/S, Ballerup, Denmark) placed 2/3rd of the way along a line between the medial condyle of the femur and the medial malleolus (according to Surface ElectroMyoGraphy for the Non-Invasive Assessment of Muscles recommendations). Electrode sites were prepared by shaving, gently abrading, and cleaning them with an alcohol-ether-acetone solution. Myoelectric signals were relayed from the bipolar electrodes to a TeleMyo device (TeleMyo 2400T, Noraxon U.S.A. Inc., Scottsdale, AZ, USA). The raw EMG signal was rectified, band-pass-filtered and integrated using commercially available software (MyoResearch XP, Noraxon U.S.A. Inc., Scottsdale, AZ, USA). EMG MPF~rate~ was then derived from the following equation:where first and final MPF represent the mean of the first 5 s and final 5 s, respectively, during the fatigue resistance test; ET is the endurance time until exhaustion.

All analyses were performed using a statistical software package (IBM SPSS Statistics 19, IBM Corp., Armonk, NY, USA). Descriptive statistics (mean ± SD) were calculated for each physiological measure during all tests. Quantitative variables were tested for normal distribution by a Shapiro-Wilk test. Relationships between physiological measures were determined using Pearson's product moment correlation coefficient. Significance at the level of p\<0.05 was used to determine the statistical significance.

RESULTS {#s3}
=======

We found that τVO~2~ was 33.9 ± 5.9 s, EMG MPF~rate~ was −14.7 ± 8.7%/s, VO~2peak~ was 50.6 ± 5.5 mL/kg/min, and MVC was 126.3 ± 25.2 Nm. [Table 1](#tbl_001){ref-type="table"}Table 1.Interrelationship between τVO~2~, EMG MPF~rate~, and VO~2peak~MeasureτVO~2~(s)EMG MPF~rate~(%/s)VO~2peak~(ml/min/kg)τVO~2~ (s)−−0.670\*−0.744\*EMG MPF~rate~ (%/s)−−0.715\*\*p\<0.05 shows interrelationships between τVO~2~, EMG MPF~rate~, and VO~2peak~ (All p\<0.05). τVO~2~ was more highly correlated with VO~2peak~ (*r* = −0.744) than EMG MPF~rate~ (*r* = −0.670). There was no significant relationship between MVC and other measures (p\>0.05).

DISCUSSION {#s4}
==========

The primary finding of the present study is that, in healthy young adults at exercise onset, the τVO~2~ measured at the alveolar level is dependent more on the ability to deliver O~2~ to skeletal muscles (VO~2peak~) than on the utilization of O~2~ in skeletal muscle (skeletal muscle fatigue resistance; EMG MPF~rate~). Our results indicate that τVO~2~ offers promise as a noninvasive index to mainly evaluate the ability of the cardiovascular system to deliver O~2~ to skeletal muscles in healthy young adults.

The present finding does not support our initial hypothesis that τVO~2~ is more highly correlated with EMG MPF~rate~ than VO~2peak~ or the findings from other studies showing no effect of O~2~ delivery on τVO~2~[@r4],[@r5],[@r6], [@r9]^)^. This may reflect that τVO~2~ is limited because of the ability to deliver O~2~ to skeletal muscles; i.e., our result may support the O~2~ delivery limitation hypothesis.

This discrepancy may be due to the fact that the limiting factor in τVO~2~ (O~2~ utilization or O~2~ delivery limitation) has not been fully revealed. The O~2~ utilization limitation hypothesis was based on the representative experiments, which showed that in older adults, but not younger adults, τVO~2~ during the transition from a priming bout of heavy-intensity exercise to moderate-intensity exercise accelerated[@r17], [@r18]^)^, and this τVO~2~ acceleration in the older adults was attributed either to an attenuation of muscle perfusion or O~2~ delivery limitation. The finding that τVO~2~ was not affected by a previous bout of heavy-intensity exercise in young adults agrees with earlier findings[@r19], [@r20]^)^, and it is consistent with the suggestion that muscle blood flow and O~2~ delivery do not limit τVO~2~ in younger adults. However, a consistent observation among these experiments was that τVO~2~ was significantly faster (approximately 20−30 s)[@r19],[@r20],[@r21]^)^ in young adults compared with that in older adults (approximately 40−60 s)[@r17], [@r18], [@r22]^)^. Thus it is unclear from these experiments whether the apparent lack of τVO~2~ acceleration during moderate-intensity exercise in young adults compared with older adults is a consequence of age-dependent differences between groups or physiological differences contributing to slower τVO~2~ in older adults compared with younger adults.

Gurd et al.[@r23]^)^ recently demonstrated that the τVO~2~ acceleration during moderate-intensity exercise after heavy-intensity warm-up exercise was not restricted to older adults and may be related to the physiological processes that control τVO~2~. In young adults exhibiting slower VO~2~ kinetics (τVO~2~ \>30 s), it was observed that τVO~2~ acceleration was associated with improvement in local muscle oxygenation, whereas this was not seen in young adults exhibiting inherently faster VO~2~ kinetics (i.e., τVO~2~, approximately 20 s). Thus, τVO~2~ acceleration was due to, in part, an increase in local muscle O~2~ delivery. More recently, this observation was supported by Murias et al.[@r24]^)^, who reported that at the onset of exercise, the rate of adjustment of near-infrared spectroscopy (NIRS)-derived muscle deoxygenation \[change in deoxyhomoglobin (HHb) concentration (∆\[HHb\]), or \[HHb\], depending on the NIRS system used (a proxy for tissue O~2~ extraction)\] during moderate-intensity exercise was faster than VO~2~ without heavy-intensity warm-up exercise, causing a period of greater reliance on O~2~ extraction for a given VO~2~. Thus, there was a transient mismatch in local muscle O~2~ delivery to O~2~ utilization \[represented as a transient "overshoot" in the normalization of the ∆\[HHb\] to VO~2~ (∆\[HHb\]/VO~2~) ratio\]; τVO~2~ was significantly reduced, and this transient overshoot in the ∆\[HHb\]/VO~2~ ratio was abolished with heavy-intensity warm-up exercise. In addition to this experiment, Murias et al.[@r25]^)^ demonstrated in a group of young men that those with the highest τVO~2~ values presented with the largest mismatch between microvascular O~2~ delivery and O~2~ utilization, which was again represented as the highest ∆\[HHb\]/VO~2~ overshoot. Furthermore, no ∆\[HHb\]/VO~2~ overshoot was observed when values from subjects with τVO~2~ \<21 s were grouped. Most recently, it was suggested that τVO~2~ is primarily limited by O~2~ provision when τVO~2~ exceeds approximately 20 s in young, healthy men[@r26]^)^. According to the above observations, it seems that when τVO~2~ \> 20 s, τVO~2~, even in healthy young adults, is primarily limited by the ability to deliver O~2~ to skeletal muscles.

In the present study, τVO~2~ may reflect the ability to deliver O~2~ to skeletal muscles because this value was found to be 33.9 ± 5.9 s (\>20 s). Therefore, τVO~2~ was more highly correlated with VO~2peak~ than EMG MPF~rate~.

In conclusion, this study demonstrated that, in healthy young adults at exercise onset, pulmonary VO~2~ kinetics during the transition to moderate-intensity exercise is dependent more on the ability to deliver O~2~ to skeletal muscles than utilization of O~2~ in skeletal muscle. This suggests that O~2~ delivery could be a possible factor regulating τVO~2~ during the onset of moderate-intensity exercise in young adults having slower VO~2~ kinetics (τVO~2~ \>20 s).
